6-bromo-3-[2-(5-methyl-1-phenyl-benzimidazol-2-yl)ethyl]chromen-4-one

ID: ALA5273125

Chembl Id: CHEMBL5273125

Max Phase: Preclinical

Molecular Formula: C25H19BrN2O2

Molecular Weight: 459.34

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc2c(c1)nc(CCc1coc3ccc(Br)cc3c1=O)n2-c1ccccc1

Standard InChI:  InChI=1S/C25H19BrN2O2/c1-16-7-10-22-21(13-16)27-24(28(22)19-5-3-2-4-6-19)12-8-17-15-30-23-11-9-18(26)14-20(23)25(17)29/h2-7,9-11,13-15H,8,12H2,1H3

Standard InChI Key:  KQQITSXTVXFAJM-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5273125

    ---

Associated Targets(Human)

PDE10A Tclin Phosphodiesterase 10A (5542 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 459.34Molecular Weight (Monoisotopic): 458.0630AlogP: 5.99#Rotatable Bonds: 4
Polar Surface Area: 48.03Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.72CX LogP: 6.40CX LogD: 6.39
Aromatic Rings: 5Heavy Atoms: 30QED Weighted: 0.33Np Likeness Score: -1.05

References

1. Ahamad S, Bhat SA..  (2022)  The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease.,  65  (24.0): [PMID:36490325] [10.1021/acs.jmedchem.2c00799]

Source